Keyphrases
Antitumor Activity
100%
HT-29
100%
Synthetic Derivatives
100%
Illudin S
100%
Mushroom Toxins
100%
Complete Regression
50%
Clinical Trials
25%
Tumor
25%
Dose-ranging
25%
Lung Adenocarcinoma
25%
Antitumor Agents
25%
Semi-synthetic
25%
Breast Carcinoma
25%
In Vitro Cytotoxicity
25%
In Vivo Antitumor Activity
25%
Novel Agents
25%
IC50
25%
Inhibition Rate
25%
Individual Animal
25%
MCF-7
25%
B16 Melanoma Cells
25%
Mammary Carcinoma Cells
25%
Tumor Xenograft
25%
Human Solid Tumors
25%
In Vitro Sensitivity
25%
Excellent Response
25%
B16 Melanoma
25%
Sesquiterpenes
25%
Human Mammary Carcinoma
25%
Colon Adenocarcinoma
25%
Human Tumor Xenograft Model
25%
Tumor Shrinkage
25%
Excellent Activity
25%
P-388 Cells
25%
Tumor Inhibition
25%
Pharmacology, Toxicology and Pharmaceutical Science
Antitumor Activity
100%
Irofulven
100%
Illudin S
100%
Neoplasm
60%
Breast Carcinoma
40%
Melanoma B16
40%
Clinical Trial
20%
Solid Malignant Neoplasm
20%
Anticarcinogen
20%
Cancer Inhibition
20%
Lung Adenocarcinoma
20%
Leukemia P 388
20%
Colon Carcinoma
20%
IC50
20%
Sesquiterpene
20%
Cytotoxicity
20%